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ABSTRACT 
. Early diagnosis and start of treatment are fundamental goals in cancer care. This study 
determines the time lag and the factors that influence the time to diagnosis and start of treatment. 
Study participants were parents of childhood cancer patients diagnosed between August 2013 
and July 2014 in a hospital in Kenya. Patient, physician, diagnosis, treatment, health care system, 
and total delay were explored using a questionnaire. Demographic and medical data were 
collected from the patients' medical records. Parents of 99 childhood cancer patients were 
interviewed (response rate: 80%). Median total delay was 102 (9–1021) days. Median patient 
delay (4 days) was significantly shorter than health care system delay (median 87 days;P < .001). 
Diagnosis delay (median 94 days) was significantly longer than treatment delay (median 6 
days; P < .001). days. Lack of health insurance at diagnosis and use of alternative medicine 
before attending conventional health services were associated with a significantly longer patient 
delay (P = .041 and P = .017, respectively). The type of cancer had a significant effect on 
treatment delay (P = .020). The type of health facility attended affected only patient delay (P = 
.03). Gender, age at diagnosis, stage of disease, parents' education level or income, and distance 
from hospital did not have a significant effect on the length of any type of delay. Training on 
childhood cancer should be included in the curricula for medical training institutes. In-service 
workshops should be held for the health workers already working. Families must be obligated to 
get health insurance. Families should be encourage to attend conventional health facilities and 




Low and middle-income countries bear the greater burden of childhood malignancies as 
compared to high-income countries. Of the annual 200,000 cancer cases that occur worldwide in 
children less than 15 years, about 70-80% are found in low and middle-income countries.1-4  
Survival rates in high-income countries are up to 80%, while most countries in Africa have 
survival rates less than 30%.5-7 This scenario has been attributed to many factors including 
difficulties in accessing hospital, paucity of trained personnel, lack of investigational and 
treatment capabilities as well as late presentation.1,2,6,7 
Early diagnosis of cancer is a fundamental goal in cancer care because it gives opportunity for 
timely initiation of appropriate treatment, while the disease is at its earliest stages. Early 
diagnosis and start of treatment may improve prognosis and allow cure to be achieved with 
minimal side-effects.8 
Variations in the length of diagnosis and treatment delay may be due to differences in health-care 
systems as well as patient-related and cancer-related factors. Health-care system factors include 
access to services, knowledge of providers as well as availability of diagnostic and treatment 
capabilities. Patient-related factors include age, sex and socio-economic background of the child, 
while cancer-related factors are mainly related to its clinical presentation and progression.8,9 
 The main purpose of this paper was to assess the various types of delay’s seen among pediatric 
oncology patients at an academic hospital and to determine the factors that influence the time to 




Kenya is a low-income country in East-Africa. In 2014 Kenya had an estimated population of 45 
million people of which 42% was aged between 0-14 years. Half of all Kenyan citizens live 
below the poverty line .10,11  
The health system in Kenya is composed of government-owned and private health facilities. 
These facilities are organized in three levels; primary, secondary, tertiary. Primary health 
facilities include dispensaries, health-centers and private clinics and are mainly involved in 
health promotion and prevention and do not have admission facilities. Secondary facilities 
include mission, private and district hospitals and are able to offer a wide variety of general and 
some specialized outpatient and inpatient care. Tertiary hospitals are the national referral 
hospitals and provide sub-specialized services. The majority of population accesses health care 
by paying out of their pockets.12 Health-insurance is provided through private entities or through 
government-owned National Hospital Insurance Fund (NHIF). All persons working in the formal 
sector contribute to NHIF while those in the informal sector can join voluntarily at a cost of 
about 25 US dollars per year which covers inpatient care for the nuclear family in government-
owned facilities.13 
The study was conducted at Moi Teaching and Referral Hospital (MTRH) in Eldoret, Western 
Kenya. MTRH has a service area of 16-18 million people, which is about 40-45% of all 
inhabitants of Kenya. Although an estimated 700 childhood cancer patients under 15 years of age 
are expected in the service area of MTRH, only 100-110 children are annually diagnosed with 
cancer.14 MTRH has a bed capacity of 700 patients of which 72 beds are located on the pediatric 
ward. Twelve of the 72 beds are reserved for oncology patients. 
 
Study design 
This cross-sectional study was conducted using a semi-structured questionnaire. The focus was 
to assess the various types of delay among pediatric oncology patients seen at MTRH and to 
determine the factors that influence the time to diagnosis and start of treatment. Participants were 
parents of childhood cancer patients who were newly diagnosed between August 2013 and July 
2014. We interviewed parents of all consecutive patients.  
By definition, “patient delay” refers to time from onset of symptoms to first time patient has 
contact with conventional health-care provider regarding symptoms attributable to cancer. 
“Health-care system delay” refers to time from first presentation to health-care provider to 
initiation of treatment. “Diagnosis delay” represents time from onset of symptoms to time the 
diagnosis of cancer is confirmed. “Treatment delay” refers to time from confirmation of 
diagnosis to start of treatment. “Physician delay” refers to time from first contact with health-
care provider to confirmation of diagnosis. “Total delay” refers to time from onset of symptoms 
to initiation of therapy (Figure1).8   
Parents were asked when symptoms started and on which date they attended the first health-care 
provider. If parents could not recall the exact date of onset of symptoms and/or date of first 
contact with health-care provider, preconceived categories were used: early-mid-end of the 
month. During analysis we transformed these categories into day 5 – day 15 – day 25 
(respectively) of the month.  
The questionnaire contained open and structured questions that parents could evaluate on two to 
five-point rating scales. The items in the questionnaire had been derived from extensive literature 
studies. Questionnaire was pilot-tested for its content, clarity and cultural sensitivities on parents 
of 5 children and revised accordingly. Demographic and medical data was collected from 
medical records of childhood cancer patients: diagnosis, date of diagnosis, age at diagnosis, stage 
of disease and date of start treatment.  Respondents rendered informed consent. Anonymity and 
confidentiality were guaranteed.  Study was approved by Research Ethics Committee of MTRH. 
Data Analysis 
Data management and analysis were executed by using SPSS. For each variable frequency 
distribution, median, means and standard deviations were calculated. Kruskal-Wallis test and 
Mann-Whitney test were used to compare time lag between different categorical variables. To 
compare paired time lag between patient delay and health-care system delay and between 
diagnosis delay and treatment delay, Wilcoxon Signed-Rank test was used. Statistical 
significance was set at p<0.05.  
RESULTS 
Demographic characteristics  
Between August 2013 and July 2014, 123 children were newly diagnosed with a malignancy. 
Caretakers of 99 children (response rate 80%) were interviewed. Parents of 21 patients (17%) 
were not interviewed for different reasons: patient deceased before interview could take place 
(52%), abandonment of treatment (24%), language barrier as parents spoke a rare dialect (14%), 
refusal to participate (10%). Three patients (2%) had to be excluded from analysis because 
parents could not recall when symptoms started or what the date was of first health facility visit.  
Respondents included following caretakers: mothers (56%), fathers (21%), uncles/aunts (10%), 
grandparents (6%), siblings (4%), both parents (2%), guardian (1%). Table 1 presents parents’ 
characteristics.  
Of 99 children, 67% were male. Patients’ age at diagnosis was a mean of 6.5 years (SD=3.8) and 
median 5.7 years. Hematological tumors contributed for 54% and solid tumors for 46% of all 
cases. There were no significant differences in patients’ age at diagnosis, gender or type of 
cancer between respondents (n=99) and non-respondents (n=24).  
Various types of delay 
Table 2 presents socio-demographic and clinical characteristics and the various types of delay. 
Some parents could not tell the exact date of onset of symptoms (66%) or the exact date of first 
contact with a conventional health-care provider (55%) and therefore used the preconceived 
categories. Paired comparison of patient delay and health-care system delay showed the latter to 
be significantly longer (P<0.001). Paired comparison of diagnosis delay and treatment delay 
showed the first to be significantly longer (P<0.001). 
Onset of symptoms 
Children suffered from following major symptoms before seeking medical care: swelling (51%), 
pain (35%), fever (26%), vomiting (15%), loss of weight (13%), loss of appetite (10%), fatigue 
(8%), weakness (7%).  After noticing these symptoms parents sought advice from relatives and 
friends (50%), and decided to first wait and watch (36%). Table 2 shows patient delay. 
Distance and transportation to hospital  
Of all participants, 76% lived more than 100 km from MTRH. Travel time to MTRH was: <1 
hour (4%), 1-3 hours (41%) and >3 hours (55%). Mode of transportation to reach MTRH is: 
public transport (94%), motorbike (23%), walking (18%), private car (5%), renting motorbike 
(4%), ambulance (2%) and renting vehicle (1%). Note that some respondents reported a 
combination of transportation modes. Travelling to hospital is considered to be: expensive 
(81%), time consuming (74%) and difficult (50%). No significant difference was found between 
distance to MTRH and any type of delay (Table 2). 
Financial situation  
Minority (38%) of households have regular income. Main economic provider is: father (48%), 
both parents (25%), mother (20%), grandparents (5%), aunt (1%) and relatives (1%). Families 
lived either below (37%) or above (63%) poverty line of 1.25 USD per day. Table 2 illustrates 
that no statistically significant difference in all types of delay was found between families living 
below or above poverty line. When coming to MTRH, 71 families (72%) lose daily wages and 
40 families (41%) lose profits from farming the land. 
Health-insurance 
Most families (67%) did not have health-insurance before onset of illness and 64% did not have 
insurance when they first came to MTRH. Having health-insurance at diagnosis resulted in a 
significantly less patient delay (P=0.049) as shown in Table 2.  
Social support for alternative and conventional treatment 
Parents (58%) were advised to seek alternative treatment for disease in their child by: 
grandparents (53%), village community (51%), friends (47%), relatives (42%), spouse (26%), 
religious community (16%), medical personnel (7%) and clan elder (2%). Parents (34%) were 
advised not to attend public hospitals by: village community (50%), relatives (44%), friends 
(41%), grandparents (32%), spouse (24%), religious community (9%).  
Alternative treatment 
After noticing symptoms of the child, 58 parents (59%) sought alternative treatment for their 
children: praying ceremonies (41%), visiting herbalist (36%), special food intake (11%), and 
attending traditional healer (3%). Reasons for using alternative treatment are illustrated in Table 
3. Use of alternative medicine resulted in significantly longer patient delay (P=0.017), diagnosis 
delay (P=0.030) and total delay (P=0.033). 
First contact with conventional health-care facilities 
Patients’ first contact with a health-care facility was at primary- (60%), secondary- (38%) and 
tertiary-care level (2%).  During this first contact, patients were helped by doctor (68%) or nurse 
(32%). Most children (69%) were initially treated for one or more other illnesses: e.g. malaria 
(34%), infection (25%), pain (15%) and anemia (7%). 
Cancer education during first contact with conventional health-care facilities 
During first contact with conventional health-care provider cancer was mentioned as possible 
diagnosis to 12 parents (12%). This health-care provider subsequently encouraged parents to 
seek conventional cancer treatment (92%) and discouraged complementary alternative treatment 
(42%). Curability of cancer was discussed with 10 of these parents (83%): 90% were told that 
cancer is curable and 10% that cancer is incurable. Affordability of cancer treatment was 
discussed with 4 of these parents (33%): 3 (75%) were told cancer treatment is not affordable 
and 1 (25%) that cancer treatment is affordable. During first contact with conventional health-
care provider 20% of all parents were advised to enroll in NHIF.  
Total number of visits to conventional health-care facilities 
Table 4 illustrates type of health-care facilities patients attended prior to receiving cancer 
treatment at MTRH. Total number of visits to other conventional health-care facilities prior to 
attending MTRH ranged from 1 to 9 visits with a mean of 3 visits (SD=1.5), and median of 3 
visits. The first health facility attended significantly affected patient delay (P=0.03), but not other 
forms of delay. 
Health beliefs 
In total 81 parents (82%) had heard of cancer before their child had been diagnosed with cancer. 
These parents perceived cancer to be curable (61%), incurable (37%) or were uncertain (3%). 
Prior to coming to MTRH conventional cancer treatment was thought to be unaffordable (78%), 
affordable (11%), or parents were unsure (11%). Use of surgery in cancer treatment was believed 
to be: helpful (96%), necessary (83%), frightening (62%), causing death (46%) and spreading 
cancer (32%).  
Reasons for delay in coming to MTRH 
Many families (97%) encountered difficulties coming to MTRH for the first time. Table 5 
illustrates reasons for delay in attending MTRH. Before coming to MTRH, 25 families (25%) 
had heard of not being allowed to take your child home in public hospitals in case families are 
unable to pay their medical bills (hospital detention practices). Ten of these families (40%) 
delayed coming to MTRH because of this. Of all 99 parents, 86% stated that parents would come 
sooner to public hospitals if children were not detained over unpaid medical bills.  
First contact with MTRH 
Before attending MTRH for the first time, 23 children (23%) had already been diagnosed with 
cancer at primary- (9%), secondary- (83%) and tertiary-care level (9%). The first department at 
MTRH which parents attended was: sick child clinic (77%), eye clinic (9%), hemato-oncology 
clinic (7%), ear nose and throat clinic (3%), private wing outpatient clinic (2%), casualty clinic 
(2%) and dental clinic (1%). Most children (99%) were immediately admitted and investigated 
for cancer.  
DISCUSSION 
This study demonstrates that diagnosis and treatment delay is a major issue. Median total delay 
was 102 days. Overall patient delay (median 4 days) was considerably shorter than health-care 
system delay (median 87 days). Although the total delay figures are similar to findings in Nigeria 
where median total delay was 109 days, our figures are longer than what has been reported in 
other studies done in Africa. 15-18 A study done in Western Kenya and Uganda,  specifically 
looking at Burkitt lymphoma, reported total delays of 12.1 and 12.9 weeks respectively. This is 
shorter than what we found though  close to what we found in our Non-Hodgkin lymphoma 
patients who had a mean total delay of 73 days.19 Similar studies in Egypt and South-Africa 
reported median total delays of 47 and 34 days respectively. The short total delay reported from 
South-Africa could be a reflection of the superior infrastructure and health-care system in the 
country and is similar to total delays found in high-income countries, such as Canada which also 
has a median total delay of 34 days.15-18 
  
Health-care system delay in our study was significantly longer than patient delay. This is unlike 
what has been reported by the Nigerian study where patient delay was longer than health-care 
system delay as well as the Burkitt lymphoma study in Western Kenya. However the Egyptian 
and South-African study also demonstrated a longer health-care system delay.15-19 This may 
mean that parents in our setting come to hospital relatively fast but a lot of delays occur in the 
health-care system. These could be because medical workers are not able to suspect and make 
the right diagnosis. It could also reflect complex referral systems as well as unavailability and 
inefficiencies of equipment and personnel to make correct diagnosis. Dual physician practices 
and absenteeism could also be contributing factors. 20-21 Government should enforce policies to 
stop dual physician practices by raising government salaries and obligating doctors to work full-
time in public hospitals. Training on how to suspect and diagnose cancer among health-care 
workers could help to reduce the health-care system delay. 
The treatment delay was a median of 6 days. This is similar to what was reported in Nigeria.15 
This delay could especially occur among patients who are diagnosed in other hospitals and are 
referred to MTRH for care. It could also happen as some families take time before reaching a 
decision on whether to start treatment for their children. Some patients may be quite sick and 
supportive measures are undertaken before their treatment is initiated. The lack of consistent 
availability of senior doctors also slows down the process as their opinion may be needed before 
treatment is started.20-21 
This study did not find a significant difference in the delays between the two genders. The sex of 
the child has been found not to influence diagnosis delay in different studies. 16,17,23,24 This may 
imply that there are no differences in health-seeking behavior regardless of the gender of the 
child.  
The longest total delay was for the age group 6-10 years though it was not significantly longer 
when compared to the other age groups. Those who were less than 5 years had the shortest delay 
which could be because the common tumors in this age group are aggressive and may lead to 
faster presentation. Most studies have reported the time lag to be longer for older children. 
However in Nigeria there were no differences among the age groups. 15,16,17 
Most common diagnosis in this series was nephroblastoma, followed by non-Hodgkin lymphoma  
and acute lymphoblastic leukemia. The type of cancer only significantly affected treatment 
delay. However, it is important to note that retinoblastoma patients had the longest median 
patient delay (30 days) as well as very long median physician delay (109 days). This could imply 
that signs and symptoms of retinoblastoma are not easily recognized by parents and health-care 
providers.  
The Nigerian study found long patient and physician delays among retinoblastoma and Hodgkin 
lymphoma patients.15 Hodgkin lymphoma commonly presents in an indolent manner with 
painless adenopathy which mimics tuberculosis of lymphatic system. Given the high prevalence 
of tuberculosis in Low income settings, most of these patients are likely to be treated with anti-
tuberculosis medication and an alternative diagnosis is only sought when there is no response 
several months later.25-26 However, our median patient and physician delays for Hodgkin 
lymphoma patients were not extremely long compared to other types of cancers.  
Treatment delay was longest for Kaposi’s sarcoma, although one needs to acknowledge that 
there were only two patients. Most patients in this set-up have Human Immunodeficiency virus 
associated Kaposi sarcoma. Unless the disease is life threatening the specific treatment for 
Kaposi sarcoma is delayed and antiretrovirals are used to improve the patients’ immunity and 
reduce the Kaposi sarcoma burden. This may lead to the long treatment delay documented here.27 
The shortest total delays were among Non-Hodgkin lymphoma and acute myeloid leukemia  
patients. They also had shortest patient delays. This could be attributed to the nature of diseases 
whereby Non-Hodgkin lymphoma usually presents with rapidly enlarging mass and acute 
myeloid leukemia  presents with significant bleeding. Other authors have reported a shorter total 
delay for acute leukemia compared to solid tumors.21,22  
Only 33% of patients had health-insurance (NHIF) at time of onset of symptoms.13 Having 
insurance resulted in significantly shorter patient delay compared to those without. This is one of 
the areas that the government and other stakeholders should focus on given that we have 
previously shown that having insurance also reduces risk of abandonment and improves survival. 
28,29 
More than half of families reported use of alternative treatment before coming to MTRH. Use of 
alternative treatment resulted in significantly longer patient delay as well as diagnosis delay. 
Previous studies in this setting have shown that many families use complementary alternative 
medicine.29 While parents had valid reasons for using alternative treatment it shows that time is 
lost before they seek care in a conventional health facility. More community education would 
alleviate this though the challenges associated with accessing health-care in Kenya need to be 
addressed as well. These include long distances to facilities, poor facilities as well as the 
negative perceptions about poor service provision from health-care workers.31-32 
Parents’ level of education did not have a significant effect on either patient or total delay. Other 
studies have given contrasting reports.  In Egypt shorter total delay among parents with higher 
education level was reported.17 Studies in Nigeria and South-Africa however showed that level 
of education has no effect on total delays. The level of income also did not have an effect on the 
delays. Majority of families lived more than 100km from MTRH but this had no effect on either 
patient or total delays. The cost of travel to hospital would be expected to be an economic burden 
to most poor families. All these socio-economic factors are interrelated and did not have a 
significant effect on delay patterns. 
Hospital detention practices are not known to the majority of parents prior to coming to MTRH. 
Among those who were aware 40% reported it as a reason to delay coming to hospital and 36% 
as a reason to seek alternative treatment. Hospital detention occurs when families are not allowed 
to take their child home after discharge due to failure to pay hospital bills. This has been shown 
to have negative consequences on the families and may influence their health-seeking behaviour. 
The families feel desperate, powerless and feel the hospital is like a prison. Families may avoid 
coming to the hospital when they are aware of the detention practices.30,33,34 It may contribute to 
the lower reported than expected childhood cancer incidence (100-110 children versus 700 
children) in the service area of MTRH. 14 
In conclusion we found that total delay is much longer than has been reported in most previous 
studies. The only factor that significantly affected total delay was use of alternative treatment. 
The health-care system delay was significantly longer than patient delay. Factors associated with 
long patient delay include: health-insurance at onset of diagnosis and use of alternative 
treatment. There were no factors that significantly affected physicians’ delay as well as health-
care system delay. Treatment delay was only significantly associated with the type of cancer. 
This study had several limitations. There could have been a recall bias regarding the onset of 
symptoms and health facility attendance. Parents may also have been giving socially desirable 
answers as criticism is not encouraged in the Kenyan culture.30  
Based on our study findings, we recommend that training on childhood cancer be incorporated 
into the curricula of medical training institutions. Workshops to sensitize those already working 
should be organized as well as presentations in scientific conferences of various cadres of health 
workers Sensitization of lay communities through mass media on common symptoms of cancer 
should be organized through the division of health promotion at the Ministry of Health. The 
public also needs to be encouraged to visit conventional health facilities first whenever their 
children are unwell. The government should make it mandatory to register with NHIF when 
acquiring the national identity card at the age of 18 years as well as when children get their birth 
certificates.  
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